Trevena, Inc.
Beta-Arrestin Effectors and Compositions and Methods of Use Thereof
Last updated:
Abstract:
This application describes a family of compounds acting as .beta.-arrestin effectors that can be used, for example, for treating acute respiratory distress syndrome, for preventing and treating thrombosis, platelet adhesion, and platelet aggregation, and/or for reducing a D-Dimer response, in a subject with ARDS or a viral infection, such as a coronavirus infection.
Status:
Application
Type:
Utility
Filling date:
20 Apr 2021
Issue date:
21 Oct 2021